title: Targeting death receptors: is this trail still hot?
authors.affiliation: Department of Pediatrics, The University of Michigan, Ann Arbor, MI 48109-5718, USA.
authors.forename: Rajen
authors.initials: R
authors.lastname: Mody
references.citation: Nat Med. 2001 Apr;7(4):383-5
references.pmid: 11283636
references.citation: Cancer Res. 2007 May 15;67(10):4981-8
references.pmid: 17510429
references.citation: Science. 1997 Apr 4;276(5309):111-3
references.pmid: 9082980
references.citation: Radiat Oncol. 2009 Oct 27;4:49
references.pmid: 19860913
references.citation: Oncogene. 2006 Feb 9;25(6):838-48
references.pmid: 16247474
references.citation: Adv Exp Med Biol. 2008;615:127-58
references.pmid: 18437894
references.citation: Leukemia. 2001 Jul;15(7):1022-32
references.pmid: 11455969
references.citation: Clin Cancer Res. 2007 Oct 15;13(20):6187-94
references.pmid: 17947486
references.citation: Int J Mol Med. 2005 Dec;16(6):1125-38
references.pmid: 16273296
references.citation: J Clin Oncol. 2007 Apr 10;25(11):1390-5
references.pmid: 17416859
references.citation: Mol Cell Biol. 2000 Jan;20(1):205-12
references.pmid: 10594023
references.citation: Nat Genet. 1997 Oct;17(2):141-3
references.pmid: 9326928
references.citation: Nat Med. 2005 Jan;11(1):77-84
references.pmid: 15619633
references.citation: J Clin Oncol. 1999 Nov;17(11):3487-93
references.pmid: 10550146
references.citation: J Clin Oncol. 2012 Jan 20;30(3):256-62
references.pmid: 22184397
references.citation: J Exp Med. 1998 Dec 7;188(11):2033-45
references.pmid: 9841917
references.citation: J Clin Invest. 2000 Apr;105(8):R15-24
references.pmid: 10772661
references.citation: Cancer Res. 2001 Feb 15;61(4):1314-9
references.pmid: 11245427
references.citation: Clin Cancer Res. 2000 Oct;6(10):4119-27
references.pmid: 11051265
references.citation: Clin Cancer Res. 2010 Apr 15;16(8):2363-74
references.pmid: 20371692
references.citation: Nat Med. 2005 Jan;11(1):71-6
references.pmid: 15619634
references.citation: Cell Death Differ. 2008 Apr;15(4):751-61
references.pmid: 18219321
references.citation: Nat Rev Cancer. 2002 Jun;2(6):420-30
references.pmid: 12189384
references.citation: Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S71-8
references.pmid: 14508083
references.citation: Oncogene. 2003 Aug 7;22(32):4953-63
references.pmid: 12902978
references.citation: J Clin Oncol. 2000 Sep;18(17):3108-14
references.pmid: 10963639
references.citation: Nat Rev Drug Discov. 2004 May;3(5):391-400
references.pmid: 15136787
references.citation: Ann Oncol. 2010 Feb;21(2):376-81
references.pmid: 19633048
references.citation: Ann Oncol. 2008 Jun;19(6):1060-7
references.pmid: 18304965
references.citation: Oncogene. 2006 Aug 24;25(37):5145-54
references.pmid: 16636678
references.citation: J Clin Oncol. 2009 Sep 10;27(26):4413-21
references.pmid: 19652058
references.citation: J Cell Biochem. 2010 May;110(1):21-34
references.pmid: 20336667
references.citation: J Pharmacol Exp Ther. 2011 Jun;337(3):644-54
references.pmid: 21385891
references.citation: Immunity. 1995 Dec;3(6):673-82
references.pmid: 8777713
references.citation: Mol Cancer Ther. 2009 Oct;8(10):2969-80
references.pmid: 19808976
references.citation: Nat Med. 2007 Sep;13(9):1070-7
references.pmid: 17767167
references.citation: Cancer Res. 2000 Feb 15;60(4):847-53
references.pmid: 10706092
references.citation: Pediatr Blood Cancer. 2012 May;58(5):729-35
references.pmid: 21630428
references.citation: Science. 1997 Aug 8;277(5327):815-8
references.pmid: 9242610
references.citation: Cancer Res. 2001 Feb 15;61(4):1645-51
references.pmid: 11245478
references.citation: J Clin Oncol. 2012 Nov 20;30(33):4141-7
references.pmid: 23071222
references.citation: Cancer Res. 2000 Oct 15;60(20):5754-60
references.pmid: 11059770